Published in Ann Biomed Eng on October 07, 2008
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol (2010) 1.21
The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis. J Gastrointest Cancer (2009) 1.19
p53 regulates metanephric development. J Am Soc Nephrol (2009) 0.99
On, around, and through: neutrophil-endothelial interactions in innate immunity. Physiology (Bethesda) (2011) 0.95
The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release. J Cell Sci (2010) 0.92
A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist. PLoS One (2010) 0.87
Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo. Chin Med J (Engl) (2015) 0.85
Heparan sulfate and heparin interactions with proteins. J R Soc Interface (2015) 0.83
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease. Biochem Pharmacol (2014) 0.82
Heparan sulfate-protein binding specificity. Biochemistry (Mosc) (2013) 0.82
Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor. J Biol Chem (2013) 0.82
hSulf-1 inhibits cell proliferation and migration and promotes apoptosis by suppressing stat3 signaling in hepatocellular carcinoma. Oncol Lett (2014) 0.78
Heparin: an intervenor in cell communication. J Cell Mol Med (2009) 0.77
Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma? Transl Gastroenterol Hepatol (2016) 0.75
Endothelial cell capture of heparin-binding growth factors under flow. PLoS Comput Biol (2010) 0.75
Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev (2005) 9.62
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
Signalling by receptor tyrosine kinases. Annu Rev Biochem (1993) 4.11
Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol (2006) 3.49
High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol (1987) 3.10
The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem (1992) 2.85
The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol (2007) 2.74
Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol (2001) 2.67
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61
Syndecans: new kids on the signaling block. Circ Res (2005) 2.43
Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest (2001) 2.35
Heparin-binding EGF-like growth factor. Biochim Biophys Acta (1997) 2.19
Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett (1999) 2.06
Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol (1993) 2.02
Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels. J Biol Chem (2003) 1.93
Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J (2006) 1.75
Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem (1986) 1.71
Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry (1992) 1.60
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57
Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry (2000) 1.47
Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem (2007) 1.18
Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. Biochemistry (1987) 1.18
pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J Biol Chem (2003) 1.13
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res (2003) 1.13
Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol (2006) 1.09
Evaluation of critical groups required for the binding of heparin to antithrombin. Proc Natl Acad Sci U S A (1984) 1.08
Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans. Biochemistry (2000) 1.05
Determination of the two-dimensional interaction rate constants of a cytokine receptor complex. Biophys J (2006) 1.04
Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem (2003) 1.03
Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry (1998) 1.00
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J (2004) 1.00
Heparin sequencing brings structure to the function of complex oligosaccharides. Proc Natl Acad Sci U S A (2000) 1.00
Transmembrane signaling by receptor oligomerization. Methods Mol Biol (1998) 0.96
The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J Theor Biol (2004) 0.95
Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol (2003) 0.93
Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry (2005) 0.90
Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding. J Theor Biol (2004) 0.81
Iodination of mouse EGF with chloramine T at 4 degrees C: characterization of the iodinated peptide and comparison with other labelling methods. J Recept Signal Transduct Res (1995) 0.79
Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A (2004) 1.98
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc Natl Acad Sci U S A (2008) 1.80
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS One (2011) 1.24
Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 1.24
Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry (2006) 1.16
pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J Biol Chem (2003) 1.13
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res (2003) 1.13
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res (2008) 1.11
Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling. J Cell Biochem (2003) 1.09
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia (2003) 1.08
A catalytic role of heparin within the extracellular matrix. J Biol Chem (2008) 1.08
Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem (2003) 1.03
Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J Biol Chem (2010) 1.03
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One (2010) 1.03
Effects of receptor clustering on ligand dissociation kinetics: theory and simulations. Biophys J (2005) 1.02
Inhibition of histone acetyltransferase by glycosaminoglycans. J Cell Biochem (2008) 1.00
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J (2004) 1.00
Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J Biol Chem (2011) 0.99
Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. J Cell Physiol (2002) 0.98
Elastase mediates the release of growth factors from lung in vivo. Am J Respir Cell Mol Biol (2004) 0.98
Effects of elastase on the mechanical and failure properties of engineered elastin-rich matrices. J Appl Physiol (1985) (2005) 0.97
PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc Natl Acad Sci U S A (2009) 0.97
Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching. Am J Physiol Lung Cell Mol Physiol (2003) 0.95
Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophys J (2011) 0.95
The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J Theor Biol (2004) 0.95
A zipper network model of the failure mechanics of extracellular matrices. Proc Natl Acad Sci U S A (2009) 0.94
Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential. J Cell Biochem (2003) 0.93
Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. FASEB J (2003) 0.92
Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts. J Biol Chem (2002) 0.92
In silico modeling of interstitial lung mechanics: implications for disease development and repair. Drug Discov Today Dis Models (2007) 0.91
Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry (2005) 0.90
New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry (2006) 0.88
Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One (2012) 0.86
Extraction and purification of decorin from corneal stroma retain structure and biological activity. Protein Expr Purif (2002) 0.84
EGF antagonizes TGF-beta-induced tropoelastin expression in lung fibroblasts via stabilization of Smad corepressor TGIF. Am J Physiol Lung Cell Mol Physiol (2008) 0.83
Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine TGF-beta on tropoelastin mRNA in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol (2006) 0.83
Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts. Am J Physiol Lung Cell Mol Physiol (2003) 0.82
Dynamics of enzymatic digestion of elastic fibers and networks under tension. Proc Natl Acad Sci U S A (2011) 0.82
Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adh Migr (2011) 0.82
A computational approach for deciphering the organization of glycosaminoglycans. PLoS One (2010) 0.81
Docking server for the identification of heparin binding sites on proteins. J Chem Inf Model (2014) 0.81
Engineering myocardial tissue patches with hierarchical structure-function. Ann Biomed Eng (2014) 0.81
A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema. Proc Natl Acad Sci U S A (2010) 0.81
Complex receptor-ligand dynamics control the response of the VEGF system to protease injury. BMC Syst Biol (2011) 0.78
Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth. J Cell Physiol (2008) 0.78
Ascorbate enhances elastin synthesis in 3D tissue-engineered pulmonary fibroblasts constructs. Tissue Cell (2013) 0.77
Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. J Cell Physiol (2012) 0.76
Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways. J Biol Chem (2013) 0.76
Extracellular matrix stiffness modulates VEGF calcium signaling in endothelial cells: individual cell and population analysis. Integr Biol (Camb) (2015) 0.76
Endothelial cell capture of heparin-binding growth factors under flow. PLoS Comput Biol (2010) 0.75
Transcriptional regulation of pulmonary elastin gene expression in elastase-induced injury. Am J Physiol Lung Cell Mol Physiol (2003) 0.75
Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models. Int J Oncol (2005) 0.75